4//SEC Filing
Arno Therapeutics, Inc 4
Accession 0000914190-16-000613
CIK 0001195116operating
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:22 PM ET
Size
10.6 KB
Accession
0000914190-16-000613
Insider Transaction Report
Form 4
Reizman Yacov
Director
Transactions
- Award
Stock Option (right to buy)
2016-04-07+88,628→ 88,628 totalExercise: $0.37Exp: 2026-04-07→ Common Stock (88,628 underlying)
Holdings
- 3,750
Stock Option (right to buy)
Exercise: $8.00Exp: 2020-11-05→ Common Stock (3,750 underlying) - 38,285(indirect: By FCC Ltd.)
Common Stock
- 68,448
Stock Option (right to buy)
Exercise: $2.40Exp: 2023-11-04→ Common Stock (68,448 underlying) - 34,224
Stock Option (right to buy)
Exercise: $2.90Exp: 2024-01-24→ Common Stock (34,224 underlying)
Footnotes (4)
- [F1]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F2]Currently exercisable.
- [F3]Vests in equal 36-monthly installments commencing 12/4/13.
- [F4]Vests in equal 12-monthly installments commencing 5/7/16.
Documents
Issuer
Arno Therapeutics, Inc
CIK 0001195116
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001195116
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:22 PM ET
- Size
- 10.6 KB